The global Positron Emission Tomography Scanners Market Growth Accelerated by Increasing Demand for Early Disease Detection and Diagnosis

 


Positron Emission Tomography Scanners are medical imaging devices that use radioactive tracers and integrated electronic circuitry to produce three-dimensional images of functional processes in the body. PET scans are useful for detecting cancer, heart disease and brain disorders. They enable physicians to easily visualize and evaluate physiological processes inside the body at the molecular level. PET scans provide better resolution and sensitivity than other scans like CT or MRI which rely only on anatomical changes.

The global Positron Emission Tomography Scanners Market is estimated to be valued at US$ 2.5 Bn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the key trends driving the growth of the Positron Emission Tomography Scanners market is the increasing demand for early disease detection and diagnosis. PET scans have proven to be effective in detecting cancers at an early stage by identifying tumor tissues and small metastases that may not be detected by other imaging methods. Early detection improves treatment outcomes and survival rates. As such, the use of PET scans is increasing among oncologists for screening, staging and restaging of various cancers. Furthermore, innovative technological advancements are allowing manufacturers to develop high resolution PET imaging systems with improved sensitivity and scan speed. This is expanding the clinical applications of PET scans and further fueling the demand.

Segment Analysis
The global positron emission tomography scanners market is dominated by the full-ring PET scanners sub segment due to their advantage of providing high image quality and wide field of view coverage for accurate diagnosis. Full-ring PET scanners dominate over partial-ring variants as they deliver maximum sensitivity coverage and access to more voxels for image reconstruction.

Key Takeaways
The global positron emission tomography scanners market is expected to witness high growth over the forecast period of 2023 to 2030 due to increasing incidence of cancer and cardiac diseases. The adoption of PET scans for tumor imaging, cardiac diagnostic procedures and neurological applications is driving market revenues.

Regional analysis
North America is currently the largest and fastest growing regional market for positron emission tomography scanners due to favorable reimbursement policies and increasing spending on medical technologies in the US and Canada.However, Asia Pacific is emerging as a lucrative market owing to rising healthcare expenditures and increasing public awareness about PET diagnostics in countries like China, India and Japan.

Key players
Key players operating in the positron emission tomography scanners market are Positron Corporation (US), CellSight Technologies. (US), RefleXion. (Canada), Clarity Pharmaceuticals (Australia), PETsys Electronics SA (Portugal), Blue Earth Diagnostics Limited. (UK), Qubiotech Health Intelligence S.L. (Spain), Advanced Accelerator Applications (France), Lily. (US), Agfa-Gevaert Group. (Belgium), CMR Naviscan. (US), Neusoft Corporation (China), Siemens (Germany), Segamicorp (US), ONCOVISION. (Spain), MedX Holdings, Inc (US), Modus Medical Devices Inc. (Canada), Radiology Oncology Systems (US), TOSHIBA CORPORATION (Japan), and General Electric Company (US), among others.

Comments

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management